Skip to content
Executive Session

Hearing statusCANCELLED: Hearing titleAuthorization for Investigation

Date:
Time: 10:00am
Location: 562 Dirksen Senate Office Building
Status: CANCELLED
There is no video broadcast for this event.

Agenda Items

Authorization for Investigation into the Outrageously High Prices Novo Nordisk Charges for Ozempic and Wegovy in the United States Compared to Other Countries

Authorization for Subpoena of Doug Langa, Executive Vice President of North America Operations for Novo Nordisk and President of Novo Nordisk Inc., for Testimony Relating to the Committee Investigation into the Outrageously High Prices Novo Nordisk Charges for Ozempic and Wegovy in the United States Compared to Other Countries